Articles citing this paper
The p3 Peptide, a Naturally Occurring Fragment of the Amyloid-β Peptide (Aβ)Found in Alzheimer's Disease, Has a Greater Aggregation Propensity In Vitro Than Full-Length Aβ, But Does Not Bind Cu2+ .
Feda Ali, Andrew J. Thompson and Colin J. Barrow
53(4) pp.321 - 326
6 articles found in Crossref database.
Copper and Zinc Mediated Oligomerisation of Aβ Peptides
Ali Feda E.,
Separovic Frances,
Barrow Colin J.,
Yao Shenggen, Barnham Kevin J.
International Journal of Peptide Research and Therapeutics. 2006 12(2). p.153
Alzheimer’s Disease “Non-amyloidogenic” p3 Peptide Revisited: A Case for Amyloid-α
Kuhn Ariel J.,
Abrams Benjamin S.,
Knowlton Stella, Raskatov Jevgenij A.
ACS Chemical Neuroscience. 2020 11(11). p.1539
Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer’s Disease?1
Kuhn Ariel J.,
Raskatov Jevgenij, Barron Annelise
Journal of Alzheimer's Disease. 2020 74(1). p.43
Copper catalysed oxidation of amino acids and Alzheimer's disease
Ali Feda E.,
Barnham Kevin J.,
Barrow Colin J., Separovic Frances
International Journal of Peptide Research and Therapeutics. 2003 10(5-6). p.405
Copper catalysed oxidation of amino acids and Alzheimer's disease
Ali Feda E.,
Barnham Kevin J.,
Barrow Colin J., Separovic Frances
International Journal of Peptide Research and Therapeutics. 2003 10(5-6). p.405
ChemInform Abstract: The p3 Peptide, a Naturally Occurring Fragment of the Amyloid‐β Peptide (Aβ) Found in Alzheimer′s Disease, Has a Greater Aggregation Propensity in vitro than Full‐Length Aβ, but Does Not Bind Cu2+.
Ali Feda,
Thompson Andrew J., Barrow Colin J.
ChemInform. 2000 31(45).
